Growth Metrics

Humana (HUM) Cash from Investing Activities (2016 - 2025)

Humana (HUM) has disclosed Cash from Investing Activities for 16 consecutive years, with $632.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities changed N/A to $632.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 billion, a N/A change, with the full-year FY2025 number at $2.3 billion, up 177.0% from a year prior.
  • Cash from Investing Activities was $632.0 million for Q4 2025 at Humana, down from $980.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $1.7 billion in Q3 2022 to a low of -$4.3 billion in Q3 2021.
  • A 4-year average of -$506.2 million and a median of -$648.0 million in 2022 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: tumbled 2772.3% in 2021, then soared 139.43% in 2022.
  • Humana's Cash from Investing Activities stood at -$102.0 million in 2021, then tumbled by 892.16% to -$1.0 billion in 2022, then decreased by 27.67% to -$1.3 billion in 2023, then skyrocketed by 148.92% to $632.0 million in 2025.
  • Per Business Quant, the three most recent readings for HUM's Cash from Investing Activities are $632.0 million (Q4 2025), $980.0 million (Q3 2025), and $347.0 million (Q2 2025).